[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Haematology](https://durgical.com/en/haematology/) › [Lymphoma and plasma cells](https://durgical.com/en/haematology/areas/lymphoid/) › Staging and treating lymphoma: PET-CT, the Lugano stages and treatment principles

# Staging and treating lymphoma: PET-CT, the Lugano stages and treatment principles

- Treatment and support

Lymphoma treatment depends on three things: which lymphoma, how far it has [spread](https://durgical.com/en/epidemiology/change-management-making-improvements-stick/) and how fit the patient is. PET-CT answers the second.

Updated Nov 15, 2026

## Key points

- Lugano: I–II limited, III–IV advanced; the [diaphragm](https://durgical.com/en/anatomy/diaphragm/) is the dividing line.
- PET-CT stages and judges response (Deauville 1–3 = complete metabolic response).
- IPI for DLBCL; FLIPI for follicular.
- Screen hepatitis B before anti-CD20.
- Hodgkin: irradiated blood; [bleomycin](https://durgical.com/en/pharmacology/bleomycin/) lungs; late [radiotherapy](https://durgical.com/en/nursing/radiation-therapy-skin-care-fatigue-and-safety-with-implants-and-radioactive-sou/) effects.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- How it is done (and why)
- Common traps
- Elsewhere in DurgiPedia

- Treatment Treatment principles by type

- Safety Risks and precautions
- Monitoring and next step

- Study Test yourself

- Connections Connections

## What it is

Staging maps where the lymphoma is. PET-CT, which shows sugar-hungry tissue, is the standard for most lymphomas that take up the tracer, including Hodgkin, DLBCL and [follicular lymphoma](https://durgical.com/en/general-pathology/follicular-lymphoma/). The Lugano classification groups stages I–II as limited disease and III–IV as advanced; bulk (a very large mass) and B symptoms add risk. Treatment is then chosen by lymphoma type, stage, prognostic scores and fitness, and response is checked by repeat PET using the five-point Deauville scale.

## How to think about it

Staging is a map with one key line: the diaphragm. Disease on one side, in one or two regions, is a local fire (I–II) that may need shorter treatment, sometimes with radiotherapy. Disease on both sides or in organs outside the nodes is a spreading fire (III–IV) that needs full systemic treatment. PET is the heat camera: it shows where the fire is at the start and whether any embers are left at the end.

## What to know

- Stage I: one node region (or one extranodal site, IE); II: two or more regions on the same side of the diaphragm; III: nodes on both sides, or above the diaphragm plus the [spleen](https://durgical.com/en/anatomy/spleen/); IV: spread to organs such as marrow, [liver](https://durgical.com/en/anatomy/liver/) or lung.
- B symptoms: unexplained fever above 38 °C, drenching night sweats, loss of more than 10% of body weight in six months; in Lugano they are recorded for [Hodgkin lymphoma](https://durgical.com/en/conditions/hodgkin-lymphoma/).
- Bulky disease: a mass of about 10 cm or more, or a mediastinal mass wider than a third of the chest, which changes treatment in early-stage disease.
- PET-CT has largely replaced routine bone marrow biopsy for staging Hodgkin lymphoma and DLBCL.
- Deauville scores 1–3 at the end of treatment usually mean complete metabolic response; 4–5 mean residual active disease, which may need biopsy.
- Prognostic scores: IPI for DLBCL (age, LDH, [performance status](https://durgical.com/en/general-pathology/newly-diagnosed-cancer-the-clinical-approach/), stage, extranodal sites); FLIPI for follicular lymphoma.

## How it is done (and why)

- Confirm the exact type on an excision or core biopsy; treatment differs completely between types.
- Stage with PET-CT, and add bone marrow biopsy only when PET cannot answer the question.
- Score the risk: stage, bulk, B symptoms, LDH, IPI or FLIPI, and the patient's fitness and heart, lung and kidney function.
- Prepare: hepatitis B, C and HIV tests, echocardiogram before anthracyclines, lung function before bleomycin, [fertility preservation](https://durgical.com/en/obstetrics-gynaecology/fertility-preservation/), vaccines.
- Treat by principle and type: Hodgkin, DLBCL and indolent lymphoma each follow their own plan (see the table below).
- Interim PET in Hodgkin lymphoma guides whether to intensify or reduce treatment.
- End-of-treatment PET defines response; relapsed aggressive lymphoma may go to salvage chemotherapy and autologous transplant, CAR-T or bispecifics.

## Treatment principles by type

| Lymphoma | Limited stage (I–II) | Advanced stage (III–IV) | Key toxicity to watch |
| --- | --- | --- | --- |
| Hodgkin | Short combination chemotherapy, often with involved-site radiotherapy | Longer ABVD-type or brentuximab-containing combination chemotherapy, adjusted by interim PET | Bleomycin lung injury, late heart and breast effects after mediastinal radiotherapy |
| DLBCL | Anti-CD20 plus chemotherapy, fewer cycles, sometimes radiotherapy | Anti-CD20 plus anthracycline-based chemotherapy; CNS prophylaxis if high CNS risk | Anthracycline heart damage, neuropathy, hepatitis B reactivation |
| Follicular | Radiotherapy can be curative | Watch if low burden; anti-CD20 based when symptomatic or bulky | Infections from long B-cell depletion |
| Gastric MALT | H. pylori eradication, then radiotherapy if needed | Anti-CD20 based therapy | Monitor for regression by endoscopy |

## Risks and precautions

- Hepatitis B reactivation during anti-CD20 therapy can cause fatal liver failure; carriers and those with past infection receive antiviral prophylaxis.
- Bleomycin lung toxicity presents as cough and [breathlessness](https://durgical.com/en/physiology/hypercapnia-and-dyspnea-what-excess-co-does-and-why-breathlessness-is-felt/); patients who have received it are given only the [oxygen](https://durgical.com/en/pharmacology/oxygen/) they need in later anaesthesia.
- Young women treated with mediastinal radiotherapy for Hodgkin lymphoma have a higher lifetime risk of [breast cancer](https://durgical.com/en/conditions/breast-cancer/) and need earlier screening.
- Patients with Hodgkin lymphoma need irradiated cellular blood components, to prevent transfusion-associated [graft-versus-host disease](https://durgical.com/en/conditions/graft-versus-host-disease/).
- Fertility preservation is offered before treatment, because [alkylating agents](https://durgical.com/en/pharmacology/classes/alkylating-agents/) and pelvic radiotherapy can cause infertility.

## Monitoring and next step

- Baseline: full count, LDH, liver and kidney tests, [uric acid](https://durgical.com/en/biochemistry/molecules/uric-acid/), hepatitis B surface antigen and core antibody, hepatitis C, HIV.
- Before anthracyclines: echocardiogram; before bleomycin: lung function tests.
- Interim PET in Hodgkin lymphoma, and end-of-treatment PET for all FDG-avid lymphomas, read with the Deauville scale.
- Deauville 4–5 at the end of treatment, or a new lesion: biopsy before labelling it relapse.

## Common traps

- **Placing the spleen in the wrong stage**: in Lugano spleen involvement with nodes above the diaphragm is stage III, not IV.
- **Calling every PET-positive residual mass relapse**: inflammation and healing can take up tracer; biopsy Deauville 4–5 before changing treatment.
- **Starting anti-CD20 therapy without hepatitis B core antibody testing**: the test comes before treatment.
- **Ordering a routine marrow biopsy in Hodgkin lymphoma**: PET-CT already shows the marrow.
- **Treating asymptomatic low-burden follicular lymphoma at once**: it adds toxicity without improving survival.

## Test yourself

Think of the answer, then tap the question to see it.

## A patient has nodes in the neck and the mediastinum only. Which Lugano stage is this, and why?

Stage II: two or more node regions, all on the same side (above) the diaphragm.

## Why has PET-CT replaced routine bone marrow biopsy for staging Hodgkin lymphoma?

PET-CT detects marrow involvement reliably as focal uptake, and a biopsy adds little when PET is clear or already shows it.

## An end-of-treatment PET shows a Deauville score of 5 in one node. What is the next step?

Biopsy the active site before calling it relapse, because inflammation can also take up the tracer; confirmed disease then leads to salvage treatment.

## Which blood test must precede rituximab, and why?

Hepatitis B surface antigen and core antibody, because anti-CD20 therapy can reactivate hepatitis B and cause fatal hepatitis unless antiviral prophylaxis is given.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/haematology/staging-and-treating-lymphoma-pet-ct-the-lugano-stages-and-treatment-principles/)

## Elsewhere in DurgiPedia

- [Nuclear medicine and PET: how they work](https://durgical.com/en/radiology/nuclear-medicine-and-pet-how-they-work/)
- [Hodgkin lymphoma](https://durgical.com/en/general-pathology/hodgkin-lymphoma/)
- [Diffuse large B-cell lymphoma](https://durgical.com/en/general-pathology/diffuse-large-b-cell-lymphoma/)
- [Follicular lymphoma](https://durgical.com/en/general-pathology/follicular-lymphoma/)
- [Cancer immunotherapy: checkpoint inhibitors, CAR-T and vaccines](https://durgical.com/en/immunology/cancer-immunotherapy-checkpoint-inhibitors-car-t-and-vaccines/)
- [Leukaemia, lymphoma and stem-cell transplant: nursing care and graft-versus-host warning signs](https://durgical.com/en/nursing/leukaemia-lymphoma-and-stem-cell-transplant-nursing-care-and-graft-versus-host-w/)

## Connections

## Related 6

- [Hodgkin versus non-Hodgkin lymphoma](https://durgical.com/en/haematology/hodgkin-versus-non-hodgkin-lymphoma/)
- [Slow and fast non-Hodgkin lymphomas: follicular, marginal zone, mantle cell, DLBCL, Burkitt](https://durgical.com/en/haematology/slow-and-fast-non-hodgkin-lymphomas-follicular-marginal-zone-mantle-cell-dlbcl-b/)
- [Enlarged lymph nodes: reactive, infected or malignant?](https://durgical.com/en/haematology/enlarged-lymph-nodes-reactive-infected-or-malignant/)
- [Stem cell transplantation: autologous or allogeneic, and what can go wrong](https://durgical.com/en/haematology/stem-cell-transplantation-autologous-or-allogeneic-and-what-can-go-wrong/)
- [Antibodies, bispecifics and CAR-T cells: how they work and their emergencies (CRS, ICANS)](https://durgical.com/en/haematology/antibodies-bispecifics-and-car-t-cells-how-they-work-and-their-emergencies/)
- [Tumour lysis syndrome: prevent, recognise, treat](https://durgical.com/en/haematology/tumour-lysis-syndrome-prevent-recognise-treat/)

## Related conditions 5

- [Hodgkin lymphoma](https://durgical.com/en/conditions/hodgkin-lymphoma/)
- [Non-Hodgkin lymphoma](https://durgical.com/en/conditions/non-hodgkin-lymphoma/)
- [Helicobacter pylori gastritis](https://durgical.com/en/conditions/helicobacter-pylori-gastritis/)
- [Primary central nervous system lymphoma](https://durgical.com/en/conditions/primary-central-nervous-system-lymphoma/)
- [Superior vena cava syndrome](https://durgical.com/en/conditions/superior-vena-cava-syndrome/)

## In Pharmacology 6

- [Rituximab](https://durgical.com/en/pharmacology/rituximab/)
- [Doxorubicin](https://durgical.com/en/pharmacology/doxorubicin/)
- [Cyclophosphamide](https://durgical.com/en/pharmacology/cyclophosphamide/)
- [Vincristine](https://durgical.com/en/pharmacology/vincristine/)
- [Prednisone](https://durgical.com/en/pharmacology/prednisone/)
- [Bendamustine](https://durgical.com/en/pharmacology/bendamustine/)

[← All of haematology](https://durgical.com/en/haematology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: [Nuclear Medicine PET/CT Lymphomas Assessment, Protocols, and Interpretation](https://www.ncbi.nlm.nih.gov/books/NBK585116/) (StatPearls (NCBI Bookshelf), 2026); [Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version](https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq) (National Cancer Institute (NCI), 2026); [Hodgkin Lymphoma Treatment (PDQ®)–Patient Version](https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq) (National Cancer Institute (NCI), 2026); [PET scan: MedlinePlus Medical Encyclopedia](https://medlineplus.gov/ency/article/003827.htm) (MedlinePlus, U.S. National Library of Medicine, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/haematology/staging-and-treating-lymphoma-pet-ct-the-lugano-stages-and-treatment-principles/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/haematology/staging-and-treating-lymphoma-pet-ct-the-lugano-stages-and-treatment-principles/
